ScholarIQanswers from OpenAlex & ORCID
Keith L. Black
ResearcherPublications, citations & collaboration network
Keith L. Black is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Keith L. Black have?
ScholarIQindexed works
Keith L. Black has 628 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Keith L. Black have?
ScholarIQcitation count
Keith L. Black has 31,750 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Keith L. Black?
ScholarIQh-index
Keith L. Black has an h-index of 87 in OpenAlex.
What is the i10-index of Keith L. Black?
ScholarIQi10-index
Keith L. Black has an i10-index of 325 in OpenAlex.
What is the ORCID of Keith L. Black?
ScholarIQorcid
The ORCID for Keith L. Black is on the source record.
What is the OpenAlex record for Keith L. Black?
ScholarIQopenalex
The OpenAlex for Keith L. Black is on the source record.
What are the most-cited papers on Keith L. Black?
ScholarIQmost cited works
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli, Floris P Barthel, Tathiane M. Malta, Thaís S. Sabedot, Sofie R. Salama, Bradley A. Murray, Olena Morozova, Yulia Newton, Amie Radenbaugh, Stefano Maria Pagnotta, Samreen Anjum, Jiguang Wang, Ganiraju C. Manyam, Pietro Zoppoli, Shiyun Ling, Arjun A. Rao, Mia Grifford, Andrew D. Cherniack, Hailei Zhang, Laila Poisson, Carlos Gilberto Carlotti, Daniela Pretti da Cunha Tirapelli, Arvind Rao, Tom Mikkelsen, Ching C. Lau, W. K. Alfred Yung, Raúl Rabadán, Jason T. Huse, Daniel J. Brat, Norman L. Lehman, Jill S. Barnholtz‐Sloan, Siyuan Zheng, Kenneth R. Hess, Ganesh Rao, Matthew Meyerson, Rameen Beroukhim, Lee Cooper, Rehan Akbani, Margaret Wrensch, David Haussler, Kenneth D. Aldape, Peter W. Laird, David H. Gutmann, Houtan Noushmehr, Antonio Iavarone, Roel G.W. Verhaak, Samreen Anjum, Harindra Arachchi, J. Todd Auman, Miruna Balasundaram, Saianand Balu, Gene H. Barnett, Stephen Baylin, Sue Bell, Christopher C. Benz, Natalie Bir, Keith L. Black, Tom Bodenheimer, Lori Boice, Moiz S. Bootwalla, Jay Bowen, Christopher A. Bristow, Yaron S.N. Butterfield, Qingrong Chen, Lynda Chin, Juok Cho, Eric Chuah, Sudha Chudamani, Simon G. Coetzee, Mark L. Cohen, Howard Colman, Marta Couce, Fulvio D’Angelo, Tanja M. Davidsen, Amy Davis, John A. Demchok, Karen Devine, Li Ding, Rebecca Duell, J. Bradley Elder, Jennifer Eschbacher, Ashley Fehrenbach, Martin L. Ferguson, Scott Frazer, Gregory N. Fuller, Jordonna Fulop, Stacey Gabriel, Luciano Garofano, Julie M. Gastier-Foster, Nils Gehlenborg, Mark Gerken, Gad Getz, Caterina Giannini, William J. Gibson, Angela Hadjipanayis, D. Neil Hayes, David I. Heiman, Beth Hermes, Joe Hilty, Katherine A. Hoadley
Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
Albert Lai, Anh Tran, Phioanh L. Nghiemphu, Whitney B. Pope, Orestes E. Solis, Michael T. Selch, Emese Filka, William H. Yong, Paul S. Mischel, Linda M. Liau, Surasak Phuphanich, Keith L. Black, Scott Peak, Richard M. Green, Cynthia E. Spier, Tatjana Kolevska, Jonathan Polikoff, Louis Fehrenbacher, Robert M. Elashoff, Timothy F. Cloughesy